Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza

Journal of Medical Virology

Volumn 87, Issue 10, 2015, Pages 1649-1655

  Yoo, Jung Wan ^a   Choi, Sang Ho ^b   Huh, Jin Won ^b   Lim, Chae Man ^b   Koh, Younsuck ^b   Hong, Sang Bum ^b  

^a Gyeongsang National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Intensive care unit; Oseltamivir; Peramivir; Severe seasonal influenza

Indexed keywords

OSELTAMIVIR; PERAMIVIR; ANTIVIRUS AGENT; CYCLOPENTANE DERIVATIVE; GUANIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; TREATMENT DURATION; TREATMENT OUTCOME; CRITICAL ILLNESS; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; MIDDLE AGED; ORAL DRUG ADMINISTRATION; ORGAN DYSFUNCTION SCORE; SEASON; STATISTICS AND NUMERICAL DATA; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CRITICAL ILLNESS; CYCLOPENTANES; GUANIDINES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LENGTH OF STAY; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; OSELTAMIVIR; RETROSPECTIVE STUDIES; SEASONS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84938549010     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24232     Document Type: Article

References (27)

1. Ariano RE, Sitar DS, Zelenitsky SA, Zarychanski R, Pisipati A, Ahern S, Kanji S, Rello J, Kumar A. 2010. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 182:357-363.
2. Arya V, Carter WW, Robertson SM. 2010. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-Influenza drug, peramivir. Clin Pharmacol Ther 88:587-589.
3. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. 2010. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362:1708-1719.
4. Birnkrant D, Cox E. 2009. The emergency use authorization of peramivir for treatment of 2009 H1N1 Influenza. N Engl J Med 361:2204-2207.
5. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CBC, Uyeki TM. Novel Swine-Original Influenza A (H1N1) Virus Investigation Team. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605-2615.
6. de Jong MD, Ison MG, Monto AS, Metev H, Clark C, O'Neil B, Elder J, McCullough A, Collis P, Sheridan WP. 2014. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. Clin Infect Dis 59:e172-e185.
7. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. 2011. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60:1-24.
8. Fry AM, Perez A, Finelli L. 2011. Use of intravenous neuraminidase inhibitors during the 2009 pandemic: Results from population-based surveillance. JAMA 306:160-162.
9. Hernandez JE, Adiga R, Armstrong R, Bazan J, Bonilla H, Bradley J, Dretler R, Ison MG, Mangino JE, Maroushek S, Shetty AK, Wald A, Ziebold C, Elder J, Hollister AS. Sheridan W; eIND Peramivir Investigators. 2011. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis 52:695-706.
10. Ison MG, Hui DS, Clezy K, O'Neil BJ, Flynt A, Collis PJ, Simon TJ, Alexander WJ. 2013. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults. Antivir Ther 18 651-661.
11. Ison MG, Fraiz J, Heller B, Jaurgui L, Mills G, O'Riordan W, O'Neil B, Playford EG, Rolf JD, Sada-Diaz E, Elder J, Collis P, Hernandez JE, Sheridan WP. 2014. Intravenous peramivir for treatment of influenza in hospitalized patients. Antivir Ther 19:349-361.
12. Ison MG, Fraiz J, Heller B, Jaurgui L, Mills G, O'Riordan W, O'Neil B, Playford EG, Rolf JD, Sada-Diaz E, Elder J, Collis P, Hernandez JE, Sheridan WP. 2014. Intravenous peramivir for treatment of influenza in hospitalized patients. Antivir Ther 19:349-361.
13. Kiatboonsri S, Kiatboonsri C, Theerawit P. 2010. Fatal respiratory events caused by zanamivir nebulization. Clin Infect Dis 50:620.
14. Kim SH, Park WB, Lee CS, Kang CI, Bang JW, Kim HB, Kim NJ, Kim EB, Oh MD, Choe KW. 2006. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: Analytical strategy using propensity scores. Clin Microbiol Infect 12:13-21.
15. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y. 2011. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: Analytic strategy using propensity scores. Am J Respir Crit Care Med 183:1207-1214.
16. Kim WY, Young Suh, Kim JW, Kim SH, Kim MJ, Kim YS, Ryu HR, Han YJ, Ko MS, Chon YG, Lee GR, Choi KH, Hong SB. Korean Society of Critical Care Medicine H1N1 Collaborative. 2011. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation. Antimicrob Agents Chemother 55: 5703-5709.
17. Kohno S, Kida H, Mizuguchi M, Shimada J. S-021812 Clinical Study Group. 2010. Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection. Antimicrob Agents Chemother 54: 4568-4574.
18. Kohno S, Kida H, Mizuguchi M, Hirotsu N, Ishida T, Kadota J, Shimada J and the S-021812 Clinical Study Group. 2011a. Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients. Antimicrob Agents Chemother 55: 2803-2812.
19. Kohno S, Yen MY, Cheong HJ, Hirotsu N, Ishida T, Kadota J, Mizuguchi M, Kida H, Shimada J. S-021812 Clinical Study Group. 2011b. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection. Antimicrob Agents Chemother 55:5267-5276.
20. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, Mclntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA. Canadian Critical Care Trials Group H1N1 Collaborative. 2009. Critically ill patients with 2009 influenza A(H1N1) infection in canada. JAMA 302:1872-1879.
21. Louie JK, Yang S, Yen C, Acosta M, Schechter R, Uyeki TM. 2012. Use of intravenous peramivir for treatment of severe influenza A(H1N1) pdm09. PLoS One 7:e40261.
22. Na S, Kim MN, Kim WY, Kim W, Hong SB, Lim CM, Koh Y, Kwon JW, Hong SJ, Lee SO, Chio SH, Kim YS, Woo JH, Kim SH. 2011. Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea. Scand J Infect Dis 43:19-26.
23. Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, Seymour CW, Hooper LG, Cheng PY, Goss CH, Cooke CR. 2014. The burden of influenza-associated critical illness hospitalizations. Crit Care Med 42:2325-2332.
24. Reed C, Chaves SS, Perez A, D'Mello T, Daily Kirley, Meek D, Jl, Farley, Ryan MM, Lynfield P, Morin R, Hancock CA, Bennett EB, Zansky NM, Thomas SM, Lindegren A, Schaffner ML, Finelli W. 2014. Complications Among Adults Hospitalized With Influenza: A Comparison of Seasonal Influenza and the 2009 H1N1 Pandemic. Clin Infect Dis 59:166-174.
25. World Health Organization 2009. revisedguidance. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/.
26. World Health Organization. Seasonal influenza factsheet no. 211 2014. Available at http://www.who.int/mediacentre/factsheets/fs211/en/.
27. Yu Y, Garg S, Yu PA, Kim HJ, Patel A, Merlin T, Redd S, Uyeki TM. 2012. Peramivir use for treatment of hospitalized patients with influenza A(H1N1) pdm09 under emergency use authorization, October 2009-June 2010. Clin Infect Dis 55:8-15.